BBO-8520
TBBO8520-101
Phase 1 small_molecule active
Quick answer
BBO-8520 for Non-small Cell Lung Cancer is a Phase 1 program (small_molecule) at BridgeBio Oncology Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BridgeBio Oncology Therapeutics
- Indication
- Non-small Cell Lung Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active